Study of Estrogen Receptor and Progesterone Receptor
                               Expression in Breast Ductal 
                              Carcinoma In Situ by Immunohistochemical Staining in
                              ER/PgR-Negative Invasive Breast Cancer

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Nuclear grade 1 (low nuclear grade)</td><td align="center">0%</td></tr><tr><td align="left">Nuclear grade 2 (intermediate nuclear grade)</td><td align="center">39.4%</td></tr><tr><td align="left">Nuclear grade 3 (high nuclear grade)</td><td align="center">60.6%</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

International Scholarly Research Notices

tab4

Table 4

Table 4: Study of Estrogen Receptor and Progesterone Receptor
                               Expression in Breast Ductal 
                              Carcinoma In Situ by Immunohistochemical Staining in
                              ER/PgR-Negative Invasive Breast Cancer 

Table 4 | Study of Estrogen Receptor and Progesterone Receptor
                               Expression in Breast Ductal 
                              Carcinoma In Situ by Immunohistochemical Staining in
                              ER/PgR-Negative Invasive Breast Cancer 

International Scholarly Research Notices

Study of Estrogen Receptor and Progesterone Receptor Expression in Breast Ductal Carcinoma In Situ by Immunohistochemical Staining in ER/PgR-Negative Invasive Breast Cancer

Table 4